January 17, 2025
January 17, 2025
Categories

The Winter 2025 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

Major breast cancer screening trial hits enrollment goal (features TMIST)

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

TMIST breast cancer screening trial reaches enrollment milestone, advancing precision screening techniques

Do you like it?
Read more
January 15, 2025
January 15, 2025
Categories

Press Release: Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screening

More than 108,000 women across the world joined the TMIST breast cancer screening trial of 2-D versus 3-D mammography
Do you like it?
Read more
January 14, 2025
January 14, 2025
Categories

Cellular therapies and novel targeted agents will shape the future of acute lymphoblastic leukemia management (mentions E1910)

Do you like it?
Read more
January 10, 2025
January 10, 2025
Categories

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

WATCH: A recent FDA approval of blinatumomab was supported by data from the E1910 trial

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

Active monitoring is promising for women with low-risk ductal carcinoma in situ (features E5194)

Do you like it?
Read more
January 6, 2025
January 6, 2025
Categories

Can we omit stem cell transplants in patients with mantle cell lymphoma with undetectable residual disease? (features EA4151)

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group